Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2-CZ-PREVAL-II Study

NCT05096962 is registered in ClinicalTrials.gov with Institute of Health Information and Statistics of the Czech Republic as lead sponsor.

NCT NCT05096962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05096962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2-CZ-PREVAL-II Study
Lead sponsor
Institute of Health Information and Statistics of the Czech Republic
Phase
Observational
Overall status
Completed
Start date
September 13, 2021
Completion date
February 24, 2022
Enrollment
7,268 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 infection